Skip to main content

Day: February 24, 2026

BIO-key and RunLevel Strengthen Identity Security Across Mozambique’s National Payments Infrastructure for Sociedade Interbancária de Moçambique (SIMO)

Multi-year agreement supports secure digital transformation of banking services and interbank systems MAPUTO, Mozambique and HOLMDEL, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (NASDAQ: BKYI), a global leader in biometric-centric Identity and Access Management (IAM) solutions, today announced a new strategic, multi-year agreement with Sociedade Interbancária de Moçambique (SIMO), the operator of Mozambique’s national electronic payments network. Working in partnership with RunLevel, a specialized regional integrator with identity and cybersecurity experience across Africa, BIO-key will support the modernization of identity and access security across SIMO’s financial ecosystem. The agreement builds on BIO-key’s and RunLevel’s first joint IAM deployment in Mozambique, in May 2025, for a major National Bank. Under...

Continue reading

Aspo Plc – Managers’ Transactions – Miska Kuusela

Aspo Plc Managers’ transactions February 24, 2026 at 11.30 EET    Aspo Plc – Managers’ Transactions – Miska Kuusela____________________________________________Person subject to the notification requirementName: Miska KuuselaPosition: Other senior managerIssuer: Aspo OyjLEI: 7437000TB0GHDHLPX677Notification type: INITIAL NOTIFICATIONReference number: 144358/4/8____________________________________________Transaction date: 2026-02-20Outside a trading venueInstrument type: SHAREISIN: FI0009008072Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 2120 Unit price: 0 EUR Aggregated transactions (1):Volume: 2120 Volume weighted average price: 0 EURAspo Plc Erkka Repo CFO Distribution: Nasdaq Helsinki www.aspo.com For more information, please contact: Erkka Repo, CFO, Aspo Plc, tel....

Continue reading

Prosafe SE: Operational update – January 2026

24 February 2026 – Fleet utilisation for January 2026 was 100%.   In Brazil, Safe Eurus, Safe Notos, and Safe Zephyrus continued to operate at full capacity in January, delivering near 100 % commercial uptime.  Safe Caledonia maintained 100% commercial uptime at the Captain Field in the UK. The vessel ended the contract for Ithaca Energy on 22 February 2026 following the exercise of all option periods. The vessel has a Letter of Intent (LoI) from Ithaca Energy for 6 months firm and 3 months of options from the second quarter of 2027.   Safe Boreas continued to receive full day rate, awaiting commencement of the 15-month firm period upon gangway connection, expected in the first quarter of 2026.   “We are very pleased with the cooperation with Ithaca Energy since entering contract in August 2024. Since June 2025, the Safe Caledonia...

Continue reading

Novo Nordisk: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk In a placebo-controlled phase 2 trial in Chinese people with overweight or obesity, UBT251 led to a statistically significant mean weight loss of up to 19.7% after 24 weeks UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies.Guangdong, China and Bagsværd, Denmark, 24 February 2026 – The United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) today announced topline results from a Chinese phase 2 trial of UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon (triple G). UBT251 is being jointly developed by TUL’s wholly-owned subsidiary The United Bio-Technology (Hengqin) Co., Ltd. (United...

Continue reading

Futu to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

HONG KONG, Feb. 24, 2026 (GLOBE NEWSWIRE) — Futu Holdings Limited (“Futu” or the “Company”) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before U.S. markets open on March 12, 2026. Futu’s management will hold an earnings conference call on Thursday, March 12, 2026, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Please note that all participants will need to pre-register for the conference call, using the link https://register-conf.media-server.com/register/BIe49e3331c0f24a9d9926d5b979ab55df It will automatically lead to the registration page of “Futu Holdings Ltd Fourth Quarter and Full Year 2025 Earnings Conference Call”,...

Continue reading

LIFT Signs Definitive Purchase Agreement with SOQUEM for a 25% Interest in the Galinée Property, Quebec

VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) — Li-FT Power Ltd. (“LIFT” or the “Company”) (TSXV: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is pleased to announce further to its December 15, 2025 press release regarding, among other things, LIFT entering into a non-binding letter of intent with SOQUEM Inc. (“SOQUEM”) and Azimut Exploration Inc., that it has entered into a definitive purchase agreement dated February 23, 2026 with SOQUEM to acquire an additional 25% interest in the exclusive exploration rights commonly known as the Galinée property (“Galinée Property”), which would bring its total aggregate interest in the Galinée Property to a 75% interest with the remainder of the interest in the Galinée Property to remain held by SOQUEM (the “SOQUEM Transaction“), subject to the satisfaction of various conditions....

Continue reading

New Earth Resources Reports Ongoing Grid Sampling and Mapping at Lucky Boy Uranium Project

Vancouver, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) — NEW EARTH RESOURCES CORP. (CSE: EATH) (“New Earth” or the “Company”) is pleased to provide an update on its ongoing exploration activities at its past-producing Lucky Boy uranium property (the “Project”). General exploration preparation followed by geologic fieldwork commenced toward the end of January 2026 and includes grid soil sampling on 100-metre line spacing with 50-metre sample intervals, in conjunction with detailed geological mapping. To date, approximately 40% of the core area of known mineralization has been systematically grid sampled. The Company is particularly encouraged from data suggesting that a relatively shallow reverse circulation (RC) drilling program conducted in 2006 tested only the upper portions of the quartzite formation hosting the uranium...

Continue reading

Miata Intersects 11.3 m at 3.58 g/t Gold and Further Expands Jons Trend Footprint at the Sela Creek Gold Project, Suriname

VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) — Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQB: MMETF) (“Miata” or the “Company”) is pleased to announce additional drill results from the Jons Trend zone at its Sela Creek Gold Project (“Sela Creek”) in Suriname. Results from the first four holes of the 2026 drill program continue to expand the existing discovery and have increased the Jons Trend mineralized footprint by approximately 20%, while remaining open for further expansion in all directions. The newly reported holes confirm extension of higher-grade mineralization across the northern portion of the system and increase the lateral extent of the zone from 250 m to 300 m. HighlightsFirst four holes of 2026 reported from Jons Trend:32 m at 1.20 grams per tonne (g/t) gold in 26DDH-JT-001 from 50 m, and 8.7...

Continue reading

Avacta’s pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis

Experimental data from FAP-Exd (AVA6103) demonstrates a more favorable profile compared to the marketed Antibody Drug Conjugate (ADC) Enhertu® Clinical trial with AVA6103 is expected to be initiated in Q1 2026 LONDON and PHILADELPHIA, Feb. 24, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, today published new data which demonstrates the favorable delivery profile and advantages of its proprietary pre|CISION platform’s compared to a marketed antibody drug conjugate (ADC). The data analysis compares pre|CISION FAP-cleavable payload delivery with that of Enhertu®, a protease cleavable-linker ADC, approved for both breast cancer and gastric cancer indications...

Continue reading

VAALCO Energy, Inc. Announces Encouraging Operational Update

HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) announced positive operational updates in Gabon and Cote d’Ivoire. The Company provided an update on its Gabon drilling program, including solid initial well results on the Etame 15H-ST well and the spudding of the next well. Additionally, the Company was confirmed as operator with a 60% working interest, with partner PetroCI having a 40% working interest in the Kossipo field, a discovery made in 2002 and later appraised in 2019 on the CI-40 block in offshore Cote d’Ivoire. Gabon Drilling HighlightsSuccessfully drilled, completed and placed on production the Etame 15H-ST development well in the 1V block of the Etame field, with a lateral of 250 meters of net pay in high-quality Gamba sands near the top of the reservoir;Stabilized...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.